from web site
View abstract. Bisogno T, Di Marzo Y. The function of the endocannabinoid system in Alzheimer's illness: truths and hypotheses. Curr Pharm Des 2008; 14( 23 ):2299 -3305. View abstract. Booz GW. Cannabidiol as an emergent therapeutic method for decreasing the impact of swelling on oxidative stress. Free Radic Biol Med 2011; 51( 5 ):1054 -61. View abstract. Bornheim LM, Everhart ET, Li J, Correia MA.
Biochem Pharmacol 1993; 45( 6 ):1323 -31. View abstract. Brady CM, Das, Gupta R, Dalton C, et al. An open-label research study of cannabis-based extracts for bladder dysfuntion in innovative several sclerosis. Mult Scler 2004; 10( 4 ):425 -33. View abstract. Campos AC, Moreira FA, Gomes FV, et al. Several systems associated with the large-spectrum healing potential of cannabidiol in psychiatric disorders.

View abstract. Cannabidiol Now Showing Up In Dietary Supplements. Natural Medicines Web site. Offered at: Accessed: May 31, 2015. Carroll CB, Bain PG, Teare L, et al. Cannabis for dyskinesia in Parkinson illness: a randomized double-blind crossover study. Neurology 2004; 63( 7 ):1245 -50. View abstract. Consroe P, Sandyk R, Snider SR. Open label evaluation of cannabidiol in dystonic movement conditions.
View abstract. Crippa JA, Derenusson GN, Ferrari TB, et al. Neural basis of anxiolytic results of cannabidiol (CBD) in generalized social anxiety condition: a preliminary report. J Psychopharmacol 2011; 25( 1 ):121 -30. View abstract. Dalterio S, Steger R, Mayfield D, Bartke A. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II.

Pharmacol Biochem Behav 1984; 20( 1 ):115 -23. View abstract. Devinsky O, Cilio MR, Cross H, et al. Cannabidiol: pharmacology and possible healing function in epilepsy and other neuropsychiatric conditions. Epilepsia 2014; 55( 6 ):791 -802. More Details . Englund A, Morrison PD, Nottage J, et al. Cannabidiol hinders THC-elicited paranoid symptoms and hippocampal-dependent memory problems. J Psychopharmacol 2013; 27( 1 ):19 -27.

Esposito G, De Filippis D, Maiuri MC, et al. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid promoted PC12 neurons through p38 MAP kinase and NF-kappa, B involvement. Neurosci Lett 2006; 399(1-2):91 -5. View abstract. Esposito G, Scuderi C, Savani C, et al. Cannabidiol in vivo blunts beta-amyloid caused neuroinflammation by reducing IL-1beta and i, NOS expression.

View abstract. FDA and Cannabis: Concerns and Answers. U.S. Food and Drug Administration Web site. Available at: https://www. fda.gov/ News, Events/Public, Health, Focus/ucm421168. htm. Accessed: May 31, 2015. Formukong EA, Evans AT, Evans FJ. Analgesic and anti-inflammatory activity of constituents of Marijuana sativa L. Swelling 1988; 12( 4 ):361 -71. View abstract. Guimaraes FS, Chairetti TM, Graeff FG, Zuardi AW.